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Abstract	Large	dual	lumen	veno-venous	(VV)	extracorporeal	membrane	oxygenation	(ECMO)	cannulas	may	increase	venous	pressure	in	the	brain,	contributing	to	intracranial	hemorrhage	(ICH).		A	retrospective	cohort	study	was	performed	using	the	extracorporeal	life	support	organization	(ELSO)	registry.		Propensity	score	matching	was	used	to	control	for	confounding.		The	rate	of	ICH	and	rates	of	hemolysis,	cannula	complications,	and	mortality	were	compared	between	adult	patients	with	a	smaller	dual	lumen	cannula	(27	to	30F)	and	patients	with	a	large	(>31F)	dual	lumen	cannula.		744	patients	were	included	in	the	propensity	score	matched	cohort.		Patients	were	well	matched	except	for	residual	imbalance	in	body	weight	and	sex.		Patients	with	a	large	cannula	had	an	ICH	rate	of	4.3%	compared	to	1.6%	in	patients	with	a	smaller	cannula	(p=0.03).		There	were	no	differences	in	hemolysis,	cannula	complications,	or	mortality	between	groups.		After	controlling	for	body	weight	and	sex	in	the	matched	cohort,	ICH	odds	remained	higher	in	patients	with	a	large	cannula;	OR=2.74,	(95%	CI=1.06	to	7.09,	p=0.03).		Our	study	data	suggest	that	large	
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dual	lumen	VV	ECMO	cannulas	are	associated	with	more	ICH	and	thus	smaller	cannulas	may	be	preferable	when	feasible.	
	
	
	
	
	
	
Introduction	Dual	lumen	veno-venous	(VV)	extracorporeal	membrane	oxygenation	(ECMO)	cannulas	are	used	for	adult	patients	with	respiratory	failure	in	many	ECMO	centers	and	have	several	potential	advantages	over	conventional	two	site	cannulation	including:	easier	ambulation	for	patients,	reduced	sedation	requirements,	and	earlier	extubation.1		Dual	lumen	cannulas	are	also	associated	with	serious	complications	related	to	their	size	and	design	including:	bleeding,	migration	into	the	right	ventricle,	and	even	right	ventricular	rupture.2-3	
	Patients	with	dual	lumen	VV	ECMO	cannulas	have	a	high	rate	of	intracranial	hemorrhage	(ICH).		In	one	cohort	of	72	patients	with	a	dual	lumen	VV	ECMO	cannula	the	rate	of	ICH	was	7%.4			There	are	a	number	of	factors	that	likely	contribute	to	this	high	ICH	rate	including	thrombocytopenia	during	ECMO,	anticoagulation,	and	possibly	intracranial	venous	hypertension	from	obstruction	of	the	internal	jugular	vein	and	superior	vena	cava	by	the	ECMO	cannula.		Further,	a	large	number	of	
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patients	develop	cannula	associated	deep	venous	thrombosis	during	ECMO,	which	may	contribute	to	intracranial	venous	hypertension.5	
	Both	smaller	and	large	dual	lumen	VV	ECMO	cannulas	are	currently	in	use.		At	the	present	time,	it	remains	unclear	which	cannula	size	is	optimal	for	the	“average”	adult	VV	ECMO	patient.		In	fact,	there	is	a	trade-off	when	considering	which	cannula	size	to	use	because	a	large	cannula	allows	for	greater	ECMO	blood	flow,	which	improves	oxygenation,	but	is	also	potentially	associated	with	more	cannula	complications	and	a	higher	rate	of	cannula	site	bleeding.2,4		To	our	knowledge,	there	are	no	clinical	studies	comparing	outcomes	between	dual	lumen	cannula	sizes.		We	hypothesized	that	large	dual	lumen	VV	ECMO	cannulas	would	be	associated	with	a	higher	rate	of	ICH	than	smaller	cannulas	given	their	larger	size.		
Methods	
Subjects	The	extracorporeal	life	support	organization	(ELSO)	registry	was	queried	to	identify	all	adult	patients	that	had	VV	ECMO	between	2011	and	2016	and	had	either	a	smaller	(27	to	30F)	or	large	(>31F)	dual	lumen	VV	ECMO	cannula.		ELSO	was	not	responsible	for	our	data	analysis	or	interpretation.		Informed	consent	was	waived	as	the	study	was	not	human	subjects	research	and	a	de-identified	dataset	was	used	for	the	analysis.		Patients	that	had	a	body	weight	above	150	kg	or	below	50	kg	were	excluded	from	the	analysis.			
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Variables	For	all	patients	we	collected	the	following	variables,	which	were	available	in	the	ELSO	database:	age,	sex,	body	weight,	cannula	size,	pre-ECMO	arrest,	FiO2	prior	to	ECMO,	peak	inspiratory	pressure	prior	to	ECMO,	positive	end	expiratory	pressure	prior	to	ECMO,	pH	prior	to	ECMO,	PaCO2	prior	to	ECMO,	PaO2	prior	to	ECMO,	intubation	hours	prior	to	ECMO,	ECMO	blood	flow	at	4	hours	and	24	hours	after	ECMO	initiation,	and	total	ECMO	hours.		
Outcomes	The	study’s	primary	outcome	variable	was	ICH,	as	defined	in	the	ELSO	registry.		Secondary	outcomes	were	significant	hemolysis,	cannula	complications,	and	in-hospital	mortality.		Significant	hemolysis	is	defined	in	the	ELSO	registry	as	plasma	free	hemoglobin	level	above	50	mg/dL.		
Sample	size	calculation	Assuming	a	7%	rate	of	ICH	in	the	high-risk	group,	an	alpha	of	5%,	and	80%	power,	a	total	of	317	patients	were	needed	in	each	group	to	detect	a	50%	lower	ICH	rate	in	the	low-risk	group.		
Statistical	analysis	Statistical	analysis	was	performed	using	SAS	9.3	(SAS	Corp,	Cary,	NC,	USA).		A	propensity	score	model	was	created	using	logistic	regression	with	the	dependent	variable	being	receipt	of	a	smaller	cannula	and	all	the	previously	mentioned	patient	
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and	ECMO	variables	entered	into	the	model	as	independent	variables.		After	propensity	scores	were	calculated	for	each	patient,	global	optimal	matching	was	used	to	create	a	propensity	score	matched	cohort.		Standardized	differences	were	calculated	to	assess	the	balance	of	covariates	in	the	matched	cohort.				Both	unadjusted	and	adjusted	odds	ratios	with	95%	confidence	intervals	were	calculated	for	the	primary	outcome	variable	and	for	secondary	outcome	variables.		Adjusted	odds	ratios	controlled	for	variables	that	could	not	be	fully	balanced	with	the	propensity	score	matching	process.	
	
Results	The	propensity	score-matched	cohort	included	744	patients.		Patient	characteristics	for	both	groups	with	standardized	differences	are	shown	in	Table	1.		All	covariates	were	well	balanced	between	the	two	groups	except	for	sex	and	body	weight,	which	had	some	residual	imbalance.		Table	2	shows	study	outcomes	by	cannula	size	group.		Patients	with	a	large	cannula	had	an	approximately	3-fold	higher	rate	of	ICH	(4.3%	vs.	1.6%,	p=0.03).		There	were	no	significant	differences	in	the	rates	of	hemolysis,	cannula	complications,	or	mortality	between	the	two	groups	(all	p>0.05).				Table	3	shows	both	unadjusted	and	adjusted	(for	body	weight	and	sex)	odds	ratios	for	study	outcomes.		The	adjusted	odds	ratio	for	ICH	with	a	large	cannula	remained	
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significant;	OR=2.83	(95%	CI=1.08	to	7.42)	after	adjusting	for	body	weight	and	sex,	but	no	other	adjusted	odds	ratio	was	significant.	
	
Discussion	Neurologic	complications	occur	in	7%	of	patients	on	VV	ECMO	with	ICH	representing	the	most	common	form	of	injury	(43%),	followed	by	brain	death	(24%),	and	ischemic	stroke	(20.0%).6		ICH	is	reported	to	occur	in	as	many	as	20%	of	adult	ECMO	patients,	depending	on	the	center,	and	is	associated	with	a	variety	of	risk	factors	including:	high	pre-cannulation	SOFA	coagulation	score,	low	platelet	count,	and	spontaneous	extracranial	hemorrhage	.7		The	mortality	rate	for	patients	with	ICH	during	ECMO	is	81%	at	1	month	and	85%	at	six	months,	reflecting	its	devastating	nature.7		To	our	knowledge,	no	prior	studies	have	evaluated	whether	cannulation	strategy	affects	the	rate	of	ICH	in	adult	patients	on	VV	ECMO.		Cannulation	strategy	has	the	potential	to	impact	ICH	rates	because	dual	lumen	VV	ECMO	cannulas,	27F	or	greater,	are	larger	than	two	site	return	cannulas,	which	are	usually	19-23F	for	adult	patients.			Dual	lumen	VV	ECMO	cannulas	can	be	used	in	most	adult	patients	who	require	VV	ECMO	and	are	associated	with	relatively	low	device	failure	and	thrombosis	rates.8-9		Dual	lumen	VV	ECMO	cannulas	are	also	associated	with	a	relatively	high	complication	rate	of	up	to	38%.			The	most	frequently	reported	complication	is	cannula	site	bleeding	(20%),	followed	by	cannula	site	infection	(10%),	and	ICH	(7%).4	
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	The	pathophysiology	of	ICH	during	VV	ECMO	is	not	fully	understood,	but	is	likely	multifactorial	and	is	related	to	platelet	dysfunction,	systemic	anticoagulation,	abnormal	production	of	procoagulant	factors	during	shock,	loss	of	large	vWF	multimers,	and	intracranial	venous	hypertension	from	deep	venous	thrombosis	(DVT)	or	cannula	related	obstruction	of	the	internal	jugular	veins.10-12		Bleeding	complications	are	common	in	adult	ECMO	patients	occurring	in	up	to	50%	of	patients.13		Cannula	associated	DVT	is	also	common	occurring	in	up	to	85%	of	ECMO	patients.5		There	are	no	animal	studies	confirming	that	VV	ECMO	cannulas	cause	venous	congestion	in	the	brain,	but	it	is	reasonable	to	assume	that	they	increase	cerebral	venous	pressure,	as	this	phenomenon	has	been	reported	in	patients	with	much	smaller	central	venous	catheters	(8F),	particularly	in	cases	of	bilateral	internal	jugular	vein	cannualtion.14		Based	on	these	observations,	we	hypothesized	that	large	dual	lumen	VV	ECMO	cannulas	would	increase	the	risk	for	ICH	and	in	fact	our	study	data	confirmed	this.		A	27F	dual	lumen	cannula	can	achieve	maximum	blood	flows	of	approximately	4.5L/min,	whereas	a	31F	cannula	can	achieve	blood	flows	up	to	6L/min.15		Because	oxygenation	is	directly	related	to	ECMO	blood	flow,	a	large	cannula	offers	a	theoretical	advantage	in	patients	with	severely	impaired	oxygenation.		However,	our	analysis	did	not	suggest	any	benefit	from	using	a	large	cannula.		In	fact,	patients	in	our	cohort	had	comparable	severity	of	pre-ECMO	lung	injury	and	ECMO	blood	flow	at	4	and	24	hours	was	equivalent.		In	addition,	there	was	no	difference	in	
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hemolysis	between	the	two	groups.		These	data	suggest	that	adequate	ECMO	blood	flow	can	be	achieved	in	an	“average”	patient	using	either	cannula	without	having	to	utilize	excessively	high	RPMs.		A	smaller	cannula	may	be	preferable	though	because	there	appears	to	be	less	ICH.	
	Our	study	has	several	critical	limitations.		First,	it	was	observational	and	data	were	pooled	in	the	ELSO	registry	from	multiple	participating	centers	with	highly	variable	practices.		Second,	although	patients	with	a	large	cannula	had	more	ICH	they	had	the	same	mortality	as	patients	with	a	smaller	cannula.		Unfortunately,	the	ELSO	database	does	not	have	data	on	quality	of	life	or	functional	outcome	so	it	is	difficult	to	discern	whether	there	was	a	difference	in	functional	survival	between	the	two	groups.		Third,	although	we	used	propensity	score	matching	to	balance	covariates	between	the	groups,	we	cannot	rule	out	the	possibility	of	residual	confounding	which	could	have	biased	our	results.		In	fact,	we	did	not	include	some	previously	described	risk	factors	for	ICH	in	our	propensity	score	analysis	because	these	data	were	not	readily	available	in	the	ELSO	registry	(eg:	daily	platelet	counts,	degree	of	anticoagulation,	type	of	anticoagulation,	and	international	normalized	ratio	values).			Finally,	in	our	cohort,	the	rates	of	ICH	were	1%	and	4%	in	the	two	groups.		This	is	quite	different	from	ICH	rates	reported	in	other	studies,	were	ICH	was	as	high	as	20%.6		Our	rate	of	ICH	is	similar	to	that	of	the	CESAR	trial,	but	we	cannot	rule	out	the	possibility	of	ICH	under-reporting	in	the	ELSO	registry.16		
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In	summary,	our	data	suggest	that	large	dual	lumen	VV	ECMO	cannulas	are	associated	with	more	ICH	than	smaller	cannulas.		There	was	no	difference	in	mortality,	hemolysis,	cannula	complications,	or	ECMO	blood	flow	at	4	and	24	hours	between	groups.		Given	these	data,	a	smaller	cannula	may	be	preferable	for	most	adult	VV	ECMO	patients.		
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Table	1.		Patient	characteristics	in	propensity	score	matched	cohort	__________________________________________________________________________________________________________________	Variable	 	 	 	 27-30F	 	 	 >31F	 		 SD	 		 	 	 	 	 N=372		 	 N=372	__________________________________________________________________________________________________________________	Age	 	 	 	 	 45	+	16	 	 	 46	+	14	 		 0.07	 						Weight	(kg)	 	 	 	 78	+	19	 	 	 82	+	18	 		 0.22	 	Sex	(%	male)	 	 	 	 150	(40.3)	 	 193	(51.9)	 		 0.23	Pre	ECMO	arrest	 	 	 24	(6.5)	 	 23	(6.2)																														0.01	 	 	 	 	 	 	 	 	Fio2	 	 	 	 	 1.0	[1.0,	1.0]	 	 1.0	[1.0,	1.0]	 	 <0.01	Peak	inspiratory	pressure	 	 35	[30,	40]	 	 35	[30,	40]	 	 <0.01	PEEP	 	 	 	 	 14	[10,	16]	 	 14	[10,	17]	 	 0.02	pH	prior	to	ECMO	 	 	 7.24	[7.14,	7.35]	 7.25	[7.15,	7.34]	 0.06	PCO2	prior	to	ECMO	 	 	 56	[43,	72]	 	 54	[42,	73]	 	 <0.01	PO2	prior	to	ECMO	 	 	 58	[44,	71]	 	 56	[44,	71]	 	 0.08	Intubation	hours	prior	to	ECMO	 48	[17,	133]	 	 48	[16,	140]	 	 0.03		Pump	flow	4	hours	 	 	 4.2	[3.7,	4.7]	 	 4.2	[3.6,	4.8]	 	 0.03	Pump	flow	24	hours																																		4.2	[3.8,	4.75]	 	 4.3	[3.8,	4.9]		 0.08	Total	ECMO	hours	 	 	 166	[87,	354]		 184	[93,	363]		 0.03	__________________________________________________________________________________________________________________	values	are	median	[interquartile	range]	or	number	(%	of	patients)	ECMO=extracorporeal	membrane	oxygenation,	PEEP=positive	end	expiratory	pressure,	SD=standardized	difference		 	
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Table	2.	Patient	outcomes	__________________________________________________________________________________________________________________	Variable	 	 	 	 27-30F	 	 	 	 >31F	 		 p	value	 	 		 	 	 	 	 N=372		 	 	 N=372	__________________________________________________________________________________________________________________	Intracranial	hemorrhage																											6	(1.6)	 	 	 	 16	(4.3)		 0.03	Hemolysis																																																						17	(4.6)	 	 	 24	(6.5)		 0.26	Cannula	complication																																	23	(6.2)	 	 	 21	(5.6)		 0.76	In	hospital	mortality		 	 145	(39.0)	 	 	 145	(39.0)		 1.0	__________________________________________________________________________________________________________________	values	are	number	(%	of	patients)			 	
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Table	3.		Adjusted	and	unadjusted	odds	ratios	for	outcomes	with	large	versus	smaller	cannulas	__________________________________________________________________________________________________________________		 	 	 	 			OR	 	 95%	CI	 	 	 p	value	__________________________________________________________________________________________________________________	
ICH	Unadjusted	 	 	 			2.74	 	 1.06	to	7.09	 	 0.03	Adjusted	for	sex	and	weight									2.83	 	 1.08	to	7.42	 	 0.03		
Hemolysis	Unadjusted	 1.44	 	 0.76	to	2.73	 	 0.26	Adjusted	for	sex	and	weight	 1.45	 	 0.76	to	2.77	 	 0.26	
	
Cannula	complication	Unadjusted	 0.91	 	 0.49	to	1.67	 	 0.76	Adjusted	for	sex	and	weight	 0.99	 	 0.53	to	1.84	 	 0.97	
	
Mortality	 	Unadjusted	 1.0	 	 0.75	to	1.34	 	 1.0	Adjusted	for	sex	and	weight	 0.99	 	 0.74	to	1.34	 	 0.97	
_________________________________________________________________________________________________
_________________	CI=confidence	interval,	ICH=intracranial	hemorrhage,	OR=odds	ratio			
